First Time Loading...
A

Aquestive Therapeutics Inc
NASDAQ:AQST

Watchlist Manager
Aquestive Therapeutics Inc
NASDAQ:AQST
Watchlist
Price: 3.255 USD 1.72%
Updated: May 15, 2024

Aquestive Therapeutics Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aquestive Therapeutics Inc
Gross Profit Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
A
Aquestive Therapeutics Inc
NASDAQ:AQST
Gross Profit
$31m
CAGR 3-Years
-5%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Gross Profit
$59.6B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Gross Profit
$34.6B
CAGR 3-Years
2%
CAGR 5-Years
16%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Gross Profit
$38.8B
CAGR 3-Years
55%
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Merck & Co Inc
NYSE:MRK
Gross Profit
$46B
CAGR 3-Years
17%
CAGR 5-Years
9%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
Gross Profit
$28.8B
CAGR 3-Years
14%
CAGR 5-Years
11%
CAGR 10-Years
5%

See Also

What is Aquestive Therapeutics Inc's Gross Profit?
Gross Profit
31m USD

Based on the financial report for Mar 31, 2024, Aquestive Therapeutics Inc's Gross Profit amounts to 31m USD.

What is Aquestive Therapeutics Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
-4%

Over the last year, the Gross Profit growth was 16%. The average annual Gross Profit growth rates for Aquestive Therapeutics Inc have been -5% over the past three years , -4% over the past five years .